BioHarvest Sciences Inc.
BHST
$1.90
-$0.01-0.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.50% | 26.90% | 37.00% | 45.88% | 57.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.50% | 26.90% | 37.00% | 45.88% | 57.83% |
| Cost of Revenue | 14.90% | 16.98% | 24.77% | 29.35% | 36.43% |
| Gross Profit | 19.39% | 34.66% | 46.87% | 59.96% | 78.03% |
| SG&A Expenses | 9.82% | 18.74% | 28.54% | 29.61% | 44.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.58% | 16.74% | 24.57% | 28.33% | 39.53% |
| Operating Income | 12.85% | 21.88% | 20.23% | 21.78% | 5.58% |
| Income Before Tax | 8.37% | -31.66% | 14.30% | 31.72% | 26.20% |
| Income Tax Expenses | 14.12% | 82.61% | 850.00% | -- | -- |
| Earnings from Continuing Operations | 8.21% | -31.93% | 13.77% | 30.86% | 25.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.21% | -31.93% | 13.77% | 30.86% | 25.67% |
| EBIT | 12.85% | 21.88% | 20.23% | 21.78% | 5.58% |
| EBITDA | 18.04% | 28.20% | 28.46% | 29.32% | 12.05% |
| EPS Basic | 24.18% | -19.26% | 27.02% | 42.48% | 40.24% |
| Normalized Basic EPS | 24.35% | -18.91% | 27.56% | 43.18% | 40.65% |
| EPS Diluted | 24.18% | -19.26% | 27.02% | 42.48% | 40.24% |
| Normalized Diluted EPS | 24.35% | -18.91% | 27.56% | 43.18% | 40.65% |
| Average Basic Shares Outstanding | 21.36% | 15.28% | 13.41% | 12.91% | 20.46% |
| Average Diluted Shares Outstanding | 21.36% | 15.28% | 13.41% | 12.91% | 20.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |